Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Carey

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Cleveland Clinic Journal of Medicine|December 1, 2005
What is a 'failure' of bisphosphonate therapy for osteoporosis?John J Carey
Clinical and Experimental Rheumatology|October 10, 2018
Current imaging techniques in osteoporosisJohn J Carey, Bjoern Buehring
Journal of Physics. Condensed Matter : an Institute of Physics Journal|July 27, 2017
Non-classical behaviour of higher valence dopants in chromium (III) oxide by a Cr vacancy compensation mechanismJohn J Carey, Michael Nolan
Rheumatology (Oxford, England)|December 22, 2010
Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)Richard Conway, John J Carey
Panminerva Medica|October 7, 2016
Methotrexate and lung disease in rheumatoid arthritisRichard Conway, John J Carey
World Journal of Hepatology|October 10, 2017
Risk of liver disease in methotrexate treated patientsRichard Conway, John J Carey
Cleveland Clinic Journal of Medicine|December 18, 2008
Bisphosphonates and osteonecrosis of the jaw: innocent association or significant risk?John J Carey, Leena Palomo
Cleveland Clinic Journal of Medicine|January 6, 2006
HypercalcemiaMiriam F Delaney, John J Carey
Bone|May 31, 2017
Utility of DXA for monitoring, technical aspects of DXA BMD measurement and precision testingJohn J Carey, Miriam F Delaney
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|February 18, 2020
Screening Doping Strategies To Mitigate Electron Trapping at Anatase TiO<sub>2</sub> SurfacesJohn J Carey, Keith P McKenna
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Cleveland Clinic Journal of Medicine|December 1, 2005
What is a 'failure' of bisphosphonate therapy for osteoporosis?John J Carey
Clinical and Experimental Rheumatology|October 10, 2018
Current imaging techniques in osteoporosisJohn J Carey, Bjoern Buehring
Journal of Physics. Condensed Matter : an Institute of Physics Journal|July 27, 2017
Non-classical behaviour of higher valence dopants in chromium (III) oxide by a Cr vacancy compensation mechanismJohn J Carey, Michael Nolan
Rheumatology (Oxford, England)|December 22, 2010
Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)Richard Conway, John J Carey
Panminerva Medica|October 7, 2016
Methotrexate and lung disease in rheumatoid arthritisRichard Conway, John J Carey
World Journal of Hepatology|October 10, 2017
Risk of liver disease in methotrexate treated patientsRichard Conway, John J Carey
Cleveland Clinic Journal of Medicine|December 18, 2008
Bisphosphonates and osteonecrosis of the jaw: innocent association or significant risk?John J Carey, Leena Palomo
Cleveland Clinic Journal of Medicine|January 6, 2006
HypercalcemiaMiriam F Delaney, John J Carey
Bone|May 31, 2017
Utility of DXA for monitoring, technical aspects of DXA BMD measurement and precision testingJohn J Carey, Miriam F Delaney
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|February 18, 2020
Screening Doping Strategies To Mitigate Electron Trapping at Anatase TiO<sub>2</sub> SurfacesJohn J Carey, Keith P McKenna
Pageof 9